Germany
Japan
United Kingdom
China
Antibodies
View as table Download
USD 524.00
In Stock
Caldesmon (CALD1) rabbit monoclonal antibody, clone EP19, Supernatant
| Applications | FC, IF, IHC, WB |
| Reactivities | Human |
USD 509.00
In Stock
USD 524.00
In Stock
USD 509.00
In Stock
CD21 (CR2) rabbit monoclonal antibody, clone EP3093, Supernatant
| Applications | FC, IF, IHC, WB |
| Reactivities | Human |
SARS-CoV-2 N Protein Rabbit Monoclonal Antibody
| Applications | ELISA, FC, IF, IHC, IP, WB |
| Reactivities | SARS-CoV-2 |
SARS-CoV-2 Spike Rabbit Monoclonal Antibody
| Applications | ELISA, FC, IF, IHC, IP |
| Reactivities | SARS-CoV-2 |
SARS-CoV-2 RBD rabbit monoclonal antibody, clone DM26
| Applications | ELISA, FC |
| Reactivities | SARS-CoV-2 |
| Conjugation | Unconjugated |
SARS-CoV-2 RBD rabbit monoclonal antibody, clone DM27
| Applications | ELISA, FC |
| Reactivities | SARS-CoV-2 |
| Conjugation | Unconjugated |
Active filters
Applications
- FC
Antibody Hosts
- Rabbit
Clonalities
- Monoclonal
Filter by
Category
Target Symbol
- CD38 (6)
- CD3E (6)
- CD4 (6)
- IL2RA (6)
- CD40 (5)
- EGFR (5)
- TNFRSF17 (5)
- CD22 (4)
- CD40LG (4)
- CD52 (4)
- IL3RA (4)
- S PROTEIN (4)
- CD19 (3)
- CD28 (3)
- CD37 (3)
- CD74 (3)
- CD8A (3)
- IL9 (3)
- SLAMF7 (3)
- AOC3 (2)
- CASP3 (2)
- CCR5 (2)
- CCRL2 (2)
- CD163 (2)
- CD27 (2)
- CD274 (2)
- CD33 (2)
- CD44 (2)
- CD53 (2)
- CD63 (2)
- CD80 (2)
- CD81 (2)
- CR1 (2)
- EPCAM (2)
- ERBB2 (2)
- FCER1G (2)
- ITGB7 (2)
- LY6G (2)
- MS4A1 (2)
- MS4A4A (2)
- MUC1 (2)
- PDCD1 (2)
- PTPRC (2)
- SELL (2)
- TAG72 (2)
- TCR (2)
- TIGIT (2)
- TIMD4 (2)
- TNFRSF18 (2)
- TNFRSF8 (2)
- TNFRSF9 (2)
- TNFSF18 (2)
- TNFSF9 (2)
- VEGFA (2)
- ABCB1 (1)
- ABCD3 (1)
- ACKR1 (1)
- ACTC1 (1)
- ADGRE1 (1)
- ADRB2 (1)
- AFP (1)
- AGER (1)
- BAD (1)
- BCL6 (1)
- BRD4 (1)
- BTLA (1)
- C3AR1 (1)
- C5AR1 (1)
- CALM2 (1)
- CCR3 (1)
- CCR7 (1)
- CCR9 (1)
- CD15 (1)
- CD16 (1)
- CD16 (FCGR3A) (1)
- CD1A (1)
- CD2 (1)
- CD200R1 (1)
- CD226 (1)
- CD276 (1)
- CD34 (1)
- CD59 (1)
- CD7 (1)
- CD70 (1)
- CD79B (1)
- CD8 (1)
- CD86 (1)
- CD8B1 (1)
- CD96 (1)
- CDC25C (1)
- CEA (1)
- CLEC4A (1)
- CLEC4M (1)
- CMKLR1 (1)
- CR2 (1)
- CSF1R (1)
- CTLA4 (1)
- CXCR1 (1)
- CXCR2 (1)
- DAXX (1)
Reactivities
Isotypes
Conjugates
Modifications
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG1 format, for improved compatibility with existing reagents, assays and techniques. (55)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG2a format, for improved compatibility with existing reagents, assays and techniques. (34)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques. (18)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG2b format, for improved compatibility with existing reagents, assays and techniques. (17)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (16)
- This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG1 format, for improved compatibility with existing reagents, assays and techniques. (16)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG1 format, for improved compatibility with existing reagents, assays and techniques. (13)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2b format, for improved compatibility with existing reagents, assays and techniques. (9)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Hamster IgG format, for improved compatibility with existing reagents, assays and techniques. (7)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human Fab format, for improved compatibility with existing reagents, assays and techniques. (7)
- This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG2a format, for improved compatibility with existing reagents, assays and techniques. (6)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgM format, for improved compatibility with existing reagents, assays and techniques. (4)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Hamster IgG2 format, for improved compatibility with existing reagents, assays and techniques. (3)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (3)
- This chimeric rabbit antibody was made using the variable domain sequences of the original human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (3)
- This chimeric rabbit antibody was made using the variable domain sequences of the original rat IgG2a format, for improved compatibility with existing reagents, assays and techniques. (3)
- This full-length, chimeric rabbit antibody was made using the variable domain sequences of the original Mouse scFv format, for improved compatibility with existing reagents, assays and techniques. (3)
- Phospho-specific (2)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG3 format, for improved compatibility with existing reagents, assays and techniques. (2)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG format, for improved compatibility with existing reagents, assays and techniques. (2)
- This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG2b format, for improved compatibility with existing reagents, assays and techniques. (2)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG4 (primatized) format, for improved compatibility with existing reagents, assays and techniques. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Armenian Hamster IgG format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Armenian Hamster IgG format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Hamster format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Hamster IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgM format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original rat IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This is a chimeric antibody created as part of a panel offering antibodies of the same specificity in different formats (species, isotype, subtype and modified versions) for use as isotype controls. (1)
Assay Types
Families
- Druggable Genome (26)
- Transmembrane (6)
- Secreted Protein (5)
- ES Cell Differentiation/IPS (4)
- Protein Kinase (4)
- Stem cell - Pluripotency (4)
- Transcription Factors (4)
- Phosphatase (2)
- Protease (2)
- Embryonic stem cells (1)
- Induced pluripotent stem cells (1)
- Stem cell relevant signaling - JAK/STAT signaling pathway (1)
- Stem cell relevant signaling - TGFb/BMP signaling pathway (1)
- Stem cell relevant signaling - Wnt Signaling pathway (1)
Pathways
- Pathways in cancer (9)
- Insulin signaling pathway (6)
- Focal adhesion (5)
- MAPK signaling pathway (5)
- Alzheimer's disease (4)
- Amyotrophic lateral sclerosis (ALS) (4)
- Colorectal cancer (4)
- ErbB signaling pathway (4)
- Acute myeloid leukemia (3)
- Adipocytokine signaling pathway (3)
- Apoptosis (3)
- Epithelial cell signaling in Helicobacter pylori infection (3)
- Hypertrophic cardiomyopathy (HCM) (3)
- Neurotrophin signaling pathway (3)
- Oocyte meiosis (3)
- Small cell lung cancer (3)
- mTOR signaling pathway (3)
- Bladder cancer (2)
- Cell cycle (2)
- Chronic myeloid leukemia (2)
- Cytokine-cytokine receptor interaction (2)
- Dilated cardiomyopathy (2)
- ECM-receptor interaction (2)
- Endometrial cancer (2)
- Glioma (2)
- GnRH signaling pathway (2)
- Huntington's disease (2)
- Jak-STAT signaling pathway (2)
- Long-term potentiation (2)
- Melanogenesis (2)
- Natural killer cell mediated cytotoxicity (2)
- Pancreatic cancer (2)
- Parkinson's disease (2)
- Prostate cancer (2)
- Regulation of actin cytoskeleton (2)
- Type II diabetes mellitus (2)
- VEGF signaling pathway (2)
- Vascular smooth muscle contraction (2)
- Viral myocarditis (2)
- Wnt signaling pathway (2)
- p53 signaling pathway (2)
- ABC transporters (1)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (1)
- Basal cell carcinoma (1)
- Calcium signaling pathway (1)
- Cardiac muscle contraction (1)
- Cell adhesion molecules (CAMs) (1)
- Fc epsilon RI signaling pathway (1)
- Hedgehog signaling pathway (1)
- Hematopoietic cell lineage (1)
- Melanoma (1)
- Non-small cell lung cancer (1)
- Nucleotide excision repair (1)
- Olfactory transduction (1)
- Phosphatidylinositol signaling system (1)
- Prion diseases (1)
- Progesterone-mediated oocyte maturation (1)
- Regulation of autophagy (1)
- Renal cell carcinoma (1)
- TGF-beta signaling pathway (1)
- Thyroid cancer (1)
- Toll-like receptor signaling pathway (1)